This post was written by Paul Sheives. FDA has issued a notice to stakeholders requesting that those parties intending to participate in periodic consultation meetings on reauthorization of the Prescription Drug User Fee Act (PDUFA) notify the agency. The first meeting will occur July 1, 2010, and FDA requests that the notices of intent be submitted by June 25, 2010.